Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
DiNAQOR Opens New GMP Manufacturing Facility in Zurich
DiNAQOR plans to open its own GMP manufacturing facility which will be located at BioTechnopark SchlierenZrich
Rocket Pharmaceuticals Constructs New R & D Manufacturing Facility
Rocket Pharmaceuticals plans to construct a new R D and manufacturing facility in Cranbury, New Jersey
Fujifilm Invests US$40 million inNew State-of-the-Art Manufacturing Facility
FUJIFILM Corporation constructs new manufacturing facility for the development of viral vectors and advanced therapies with an investment of US$40 million The new stateoftheart manufacturing facility will be located at greaterBoston area
Thermo Fisher Constructs New cGMP Plasmid DNA Manufacturing Facility in California
Thermo Fisherplans to construct a new manufacturing facility for the production of clinical and commercial capabilities The facility will be located in Carlsbad, California The expansion of this facility enhances the commercialisation of plasmidbased medicines and vaccines
KBI Biopharma Invests $150 Millionto Expand Commercial Manufacturing Facility in North California
KBI Biopharma, Inc, plans to open a new facility for commercial manufacturing The manufacturing site involves an investment of US$150 million The facility will be located atResearch Triangle Park RTP in North Carolina
Lonza to Open Two Additional Manufacturing Suites
Lonzaplans to open two additional manufacturing sites to expand the conjugation facility
Piramal PharmaPlans New Manufacturing Facility in Michigan
Piramal Pharma Solutions plans to expand with the addition of a new manufacturing facility located in Michigan
SeqirusConstructs World Class Vaccine Manufacturing Facility in Australia
Seqirus, a global leader in influenza prevention and influenza pandemic responseplans to construct a new nextgeneration vaccine manufacturing facility The new manufacturing facility will be located in Australia
Samsung Biologics Constructs Super Plant 4 in South Korea
Samsung Biologics plans to open the most innovative biomanufacturing facility with the addition of super plant 4 The modern super plant 4 will be located in Incheon, South Korea
Cambrex to Expand Large Scale API Manufacturing Capacity in US
Cambrex plans to invest US$50 million to expand new midscale and largescale API manufacturing capacity The site will be located in Iowa, US
